Page last updated: 2024-09-03

furamidine and camostat

furamidine has been researched along with camostat in 1 studies

Compound Research Comparison

Studies
(furamidine)
Trials
(furamidine)
Recent Studies (post-2010)
(furamidine)
Studies
(camostat)
Trials
(camostat)
Recent Studies (post-2010) (camostat)
1081323371493

Protein Interaction Comparison

ProteinTaxonomyfuramidine (IC50)camostat (IC50)
Transmembrane protease serine 2Homo sapiens (human)0.018
ProthrombinHomo sapiens (human)0.399
Serine protease hepsinHomo sapiens (human)0.0235
Trypsin-1Homo sapiens (human)0.0035
Trypsin-2Homo sapiens (human)0.0035
Procathepsin LHomo sapiens (human)0.018
FurinHomo sapiens (human)0.018
Trypsin-3Homo sapiens (human)0.0035
Transmembrane protease serine 6Homo sapiens (human)0.018
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barygin, OI; Zhigulin, AS1

Other Studies

1 other study(ies) available for furamidine and camostat

ArticleYear
Mechanisms of NMDA receptor inhibition by nafamostat, gabexate and furamidine.
    European journal of pharmacology, 2022, Mar-15, Volume: 919

    Topics: Animals; Benzamidines; Drug Repositioning; Esters; Gabexate; Guanidines; Hippocampus; Inhibitory Concentration 50; Male; Models, Animal; Neurodegenerative Diseases; Pyramidal Cells; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serine Proteinase Inhibitors

2022